• CHANG TSI
  인사이트

  1월07

  2026

  Implementation of the "Patent Examination Guidelines" in January 2026 — Significant Changes in Patent Invalidation Procedures

  
• CHANG TSI
  인사이트

  12월29

  2025

  A Legislative Milestone: China Releases the 2025 Draft Amendment to the Trademark Law for Review by National Lawmakers

  
• CHANG TSI
  인사이트

  12월17

  2025

  Analysis and Practical Guide to Compliance in Commercial Franchising in China

  
• CHANG TSI
  인사이트

  12월15

  2025

  UK Trademark Renewal Fees to Rise by 25% – Act Now to Secure Cost Advantages

  
• CHANG TSI
  인사이트

  12월12

  2025

  Case Review：How Administrative Complaints Can Effectively Resolve Trademark–Enterprise Name Disputes

  
• CHANG TSI
  인사이트

  12월11

  2025

  Tips For Pharmaceutical Use Claims

  
• CHANG TSI
  인사이트

  12월10

  2025

  A Practical Guide to Copyright Protection in Malaysia

  
• CHANG TSI
  인사이트

  12월08

  2025

  Understanding China’s Pharmaceuticals Patent Linkage System: Judicial Trends and Key Takeaways from Recent Cases (Part 2)

  
• CHANG TSI
  인사이트

  12월05

  2025

  Integrated Criminal-Civil Actions Achieves Significant Victory for Edelman Shoe, Inc. in IP Protection

  
• CHANG TSI
  인사이트

  12월03

  2025

  CNIPA Updates Examination Guidelines: Key Process Changes for 2026

  
• CHANG TSI
  인사이트

  11월28

  2025

  Understanding China’s Pharmaceutical Patent Linkage System: Framework and Case Overview (Part 1)

  
• CHANG TSI
  인사이트

  11월26

  2025

  Victory Against Trademark Infringement and Unfair Competition: Edelman Shoe, Inc. Secures Justice with Landmark Court Ruling

  
上一页 1 2 3 4 5 6 7 8 9 10 下一页

View More